Nilotinib 150mg

The drug is prescribed by an oncologist for chronic myeloid leukemia.
Nilotinib 150 mg is a drug that is used in the treatment of certain types of blood cancer, such as chronic myeloid leukemia with Philadelphia chromosome. The drug is a kinase inhibitor, it slows the growth of cancer cells, which has a positive effect on the course of the disease.

Pharmacological action of Nilotinib 150mg

Nilotinib 150mg demonstrates a direct cytotoxic activity against leukemia cells in the treatment of chronic myeloid leukemia. It inhibits the growth and reproduction of the affected cells and provokes apoptosis. The main advantage of this drug is a highly selective effect on cells that have undergone malignant degeneration. Despite the fact that the price of Nilotinib 150mg is relatively low, the drug has a high efficiency, and its reception can significantly prolong the life of such patients.
Your doctor will tell you about the prescribed doses of Nilotinib 150mg and other drugs, if you have been prescribed a combination treatment.

Indications for use

It is used in the treatment of the first diagnosed form of chronic myeloid leukemia, in adult patients who were diagnosed with Philadelphia chromosome. In addition, the drug is used in the treatment of accelerated and chronic phase of chronic myeloid leukemia in adult patients with Philadelphia chromosome if the patient has been diagnosed with resistant to the treatment form of the disease or intolerance to imatinib.

Drug contradictions

It is recommended to treat with caution the reception of the drug to patients who suffer from diseases of the liver, kidneys and cardiovascular system. It is also recommended to refrain from prescribing the drug to those who suffer from intolerance to nilotinib.

Side effects

The use of Nilotinib for therapeutic purposes is sometimes marked by the development of alopecia, dry skin, progressive weight loss, myalgia, arthralgia, bone pain, muscle spasms, allergic reactions, dyspeptic disorders, epigastric and abdominal pain.

Features of reception of Nilotinib 150mg

The capsules are intended for oral reception. They are swallowed as a whole in two hours after meal. The drug is taken twice a day at regular intervals. After taking the capsules, you can eat no sooner than in one hour. If a patient is unable to swallow the capsule, then its contents should be dissolved in a teaspoon of a mashed apple.